BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 21692052)

  • 1. Glucose, not glutamine, is the dominant energy source required for proliferation and survival of head and neck squamous carcinoma cells.
    Sandulache VC; Ow TJ; Pickering CR; Frederick MJ; Zhou G; Fokt I; Davis-Malesevich M; Priebe W; Myers JN
    Cancer; 2011 Jul; 117(13):2926-38. PubMed ID: 21692052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Individualizing antimetabolic treatment strategies for head and neck squamous cell carcinoma based on TP53 mutational status.
    Sandulache VC; Skinner HD; Ow TJ; Zhang A; Xia X; Luchak JM; Wong LJ; Pickering CR; Zhou G; Myers JN
    Cancer; 2012 Feb; 118(3):711-21. PubMed ID: 21720999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockage of glycolysis by targeting PFKFB3 suppresses tumor growth and metastasis in head and neck squamous cell carcinoma.
    Li HM; Yang JG; Liu ZJ; Wang WM; Yu ZL; Ren JG; Chen G; Zhang W; Jia J
    J Exp Clin Cancer Res; 2017 Jan; 36(1):7. PubMed ID: 28061878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity in 2-deoxy-D-glucose-induced modifications in energetics and radiation responses of human tumor cell lines.
    Dwarkanath BS; Zolzer F; Chandana S; Bauch T; Adhikari JS; Muller WU; Streffer C; Jain V
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):1051-61. PubMed ID: 11429233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic profiling analysis of head and neck squamous cell carcinoma.
    Ohashi T; Terazawa K; Shibata H; Inoue N; Ogawa T
    Oral Dis; 2024 Mar; 30(2):342-352. PubMed ID: 36349421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delineating metabolic signatures of head and neck squamous cell carcinoma: phospholipase A2, a potential therapeutic target.
    Tripathi P; Kamarajan P; Somashekar BS; MacKinnon N; Chinnaiyan AM; Kapila YL; Rajendiran TM; Ramamoorthy A
    Int J Biochem Cell Biol; 2012 Nov; 44(11):1852-61. PubMed ID: 22743333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of glutamine-dependent cell survival augments antitumor efficacy of CPI-613 in head and neck cancer.
    Lang L; Wang F; Ding Z; Zhao X; Loveless R; Xie J; Shay C; Qiu P; Ke Y; Saba NF; Teng Y
    J Exp Clin Cancer Res; 2021 Dec; 40(1):393. PubMed ID: 34906193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic silencing of MAL, a putative tumor suppressor gene, can contribute to human epithelium cell carcinoma.
    Cao W; Zhang ZY; Xu Q; Sun Q; Yan M; Zhang J; Zhang P; Han ZG; Chen WT
    Mol Cancer; 2010 Nov; 9():296. PubMed ID: 21092172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-Deoxy-d-glucose Suppresses the In Vivo Antitumor Efficacy of Erlotinib in Head and Neck Squamous Cell Carcinoma Cells.
    Sobhakumari A; Orcutt KP; Love-Homan L; Kowalski CE; Parsons AD; Knudson CM; Simons AL
    Oncol Res; 2016; 24(1):55-64. PubMed ID: 27178822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential cytotoxicity of the glycolytic inhibitor 2-deoxy-D-glucose in isogenic cell lines varying in their p53 status.
    Vibhuti A; Muralidhar K; Dwarakanath BS
    J Cancer Res Ther; 2013; 9(4):686-92. PubMed ID: 24518718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting cellular metabolism to reduce head and neck cancer growth.
    Yang J; Guo Y; Seo W; Zhang R; Lu C; Wang Y; Luo L; Paul B; Yan W; Saxena D; Li X
    Sci Rep; 2019 Mar; 9(1):4995. PubMed ID: 30899051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53-targeted lincRNA-p21 acts as a tumor suppressor by inhibiting JAK2/STAT3 signaling pathways in head and neck squamous cell carcinoma.
    Jin S; Yang X; Li J; Yang W; Ma H; Zhang Z
    Mol Cancer; 2019 Mar; 18(1):38. PubMed ID: 30857539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lactate as a predictive marker for tumor recurrence in patients with head and neck squamous cell carcinoma (HNSCC) post radiation: a prospective study over 15 years.
    Blatt S; Voelxen N; Sagheb K; Pabst AM; Walenta S; Schroeder T; Mueller-Klieser W; Ziebart T
    Clin Oral Investig; 2016 Nov; 20(8):2097-2104. PubMed ID: 26728026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-6 antisense-mediated growth inhibition in a head and neck squamous cell carcinoma cell line.
    Bran G; Götte K; Riedel K; Hörmann K; Riedel F
    In Vivo; 2011; 25(4):579-84. PubMed ID: 21708999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual blockade of EGFR and c-Met abrogates redundant signaling and proliferation in head and neck carcinoma cells.
    Xu H; Stabile LP; Gubish CT; Gooding WE; Grandis JR; Siegfried JM
    Clin Cancer Res; 2011 Jul; 17(13):4425-38. PubMed ID: 21622718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Pactamycin Analogs Induce p53 Dependent Cell-Cycle Arrest at S-Phase in Human Head and Neck Squamous Cell Carcinoma (HNSCC) Cells.
    Guha G; Lu W; Li S; Liang X; Kulesz-Martin MF; Mahmud T; Indra AK; Ganguli-Indra G
    PLoS One; 2015; 10(5):e0125322. PubMed ID: 25938491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin increases natural killer cell functions in head and neck squamous cell carcinoma through CXCL1 inhibition.
    Crist M; Yaniv B; Palackdharry S; Lehn MA; Medvedovic M; Stone T; Gulati S; Karivedu V; Borchers M; Fuhrman B; Crago A; Curry J; Martinez-Outschoorn U; Takiar V; Wise-Draper TM
    J Immunother Cancer; 2022 Nov; 10(11):. PubMed ID: 36328378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of MTBP expression is associated with reduced survival in a biomarker-defined subset of patients with squamous cell carcinoma of the head and neck.
    Vlatković N; El-Fert A; Devling T; Ray-Sinha A; Gore DM; Rubbi CP; Dodson A; Jones AS; Helliwell TR; Jones TM; Boyd MT
    Cancer; 2011 Jul; 117(13):2939-50. PubMed ID: 21692053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of malic enzyme 1 and 2: Sensitizing head and neck squamous cell carcinoma cells to therapy-induced senescence.
    Woo SH; Yang LP; Chuang HC; Fitzgerald A; Lee HY; Pickering C; Myers JN; Skinner HD
    Head Neck; 2016 Apr; 38 Suppl 1():E934-40. PubMed ID: 25994759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute Tumor Lactate Perturbations as a Biomarker of Genotoxic Stress: Development of a Biochemical Model.
    Sandulache VC; Chen Y; Skinner HD; Lu T; Feng L; Court LE; Myers JN; Meyn RE; Fuller CD; Bankson JA; Lai SY
    Mol Cancer Ther; 2015 Dec; 14(12):2901-8. PubMed ID: 26376962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.